Burjeel Cancer Institute
Hub71’s Vivan Therapeutics wins approval for cancer study
Vivan Therapeutics, part of Hub71 and a precision oncology company developing AI-enabled tools to match cancer patients to more effective therapies, today announced that it has received all regulatory...